Therefore, a deeper understanding of the mechanisms that regulate PD-L1 expression could lead to improved strategies for enhancing the effectiveness of PD-L1/PD-1 inhibitors in lung cancer treatment. The gene discussed is CD274; the disease is lung carcinoma.